2013 Animal Testing Drug Development 
Drug Target Review
SEPTEMBER 26, 2023
Within the field of drug safety hiPSC-cardiomyocytes are now routinely used for early identification of cardiac liabilities in drug discovery. The CiPA initiative aims to engineer an assay to assess the proarrhythmic potential of new drugs with improved specificity compared to current methods.
The Premier Consulting Blog
APRIL 25, 2023
As a result, the FDA is now required to consider alternatives to animal testing, such as in vitro , in silico , and in chemico tests and models. In this blog post, we examine several alternative approaches to animal testing and how the FDA handles the application of these methods in specific scenarios.
Expert insights. Personalized for you.
111 
Let's personalize your content